People with blood-related conditions have a higher chance of getting invasive fungal infections (IFIs). IFIs are severe fungal infections that can lead to death. Only a few medications, known as antifungals, exist that can be used to prevent IFIs, and sometimes they can cause very bad side effects. Isavuconazole is an antifungal which has been approved to treat IFIs, but it has not been approved to prevent IFIs. In this study, we reviewed published studies that looked at how well isavuconazole prevented IFIs in people who have a higher chance of getting IFIsThis Plain Language Summary of Publication article from Future Microbiology looks at isavuconazole, a treatment for people with blood-related conditions who are at a  higher chance of getting invasive fungal infections (IFIs). IFIs are severe fungal infections that can lead to death.

Read the full article here.

The original article on which this summary is based is called ‘Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting’ and was published in Hematology. 

Read the original article here.